Debut of Gastroesophageal Reflux Concomitant with Administration of Sublingual Immunotherapy
Gastroesophageal reflux disease (GORD) is an often debilitating condition characterised by retrograde flow of content from stomach into the oesophagus, where the low pH of the stomach acid irritates the mucosa of the oesophagus.The most dominant symptoms in GORD are pyrosis, regurgitation, and dysphagia.Sublingual immunotherapy (SLIT) was first des